Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations.

Loeffler DA, Smith LM, Coffey MP, Aasly JO, LeWitt PA.

J Neural Transm (Vienna) · 2015-11-03

DOI: 10.1007/s00702-015-1479-0PMID: 26526034

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2.

Konovalova EV, Novosadova EV, Grivennikov IA, Illarioshkin SN.

Bull Exp Biol Med · 2015-10-31

DOI: 10.1007/s10517-015-3072-9PMID: 26519280

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease.

Infante J, Prieto C, Sierra M, Sánchez-Juan P, González-Aramburu I, Sánchez-Quintana C, Berciano J, Combarros O, Sainz J.

Neurobiol Aging · 2015-10-31

DOI: 10.1016/j.neurobiolaging.2015.10.026PMID: 26675812

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.

Duque AF, Lopez JC, Benitez B, Hernandez H, Yunis JJ, Fernandez W, Arboleda H, Arboleda G.

Colomb Med (Cali) · 2015-09-30

DOI: 10.25100/cm.v46i3.1553PMID: 26600626

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease Using RapidFire Mass Spectrometry.

Leveridge M, Collier L, Edge C, Hardwicke P, Leavens B, Ratcliffe S, Rees M, Stasi LP, Nadin A, Reith AD.

J Biomol Screen · 2015-09-24

DOI: 10.1177/1087057115606707PMID: 26403521

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition.

Smith GA, Jansson J, Rocha EM, Osborn T, Hallett PJ, Isacson O.

Mol Neurobiol · 2015-09-23

DOI: 10.1007/s12035-015-9435-4PMID: 26399642

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Alternative to LRRK2-IN-1 for Pharmacological Studies of Parkinson's Disease.

Koshibu K, van Asperen J, Gerets H, Garcia-Ladona J, Lorthioir O, Courade JP.

Pharmacology · 2015-09-18

DOI: 10.1159/000439136PMID: 26382237

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway.

Imai Y, Kobayashi Y, Inoshita T, Meng H, Arano T, Uemura K, Asano T, Yoshimi K, Zhang CL, Matsumoto G, Ohtsuka T, Kageyama R, Kiyonari H, Shioi G, Nukina N, Hattori N, Takahashi R.

PLoS Genet · 2015-09-10

DOI: 10.1371/journal.pgen.1005503PMID: 26355680

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations.

Rudi K, Ho FY, Gilsbach BK, Pots H, Wittinghofer A, Kortholt A, Klare JP.

Biosci Rep · 2015-08-26

DOI: 10.1042/bsr20150128PMID: 26310572

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants.

Oosterveld LP, Allen JC, Ng EY, Seah SH, Tay KY, Au WL, Tan EK, Tan LC.

Neurology · 2015-08-26

DOI: 10.1212/wnl.0000000000001953PMID: 26311745

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy.

Aasly JO, Sæther O, Johansen KK, Bathen TF, Giskeødegård GF, White LR.

Parkinsons Dis · 2015-08-18

DOI: 10.1155/2015/264896PMID: 26357583

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers.

Vilas D, Ispierto L, Álvarez R, Pont-Sunyer C, Martí MJ, Valldeoriola F, Compta Y, de Fabregues O, Hernández-Vara J, Puente V, Calopa M, Jaumà S, Campdelacreu J, Aguilar M, Quílez P, Casquero P, Lomeña F, Ríos J, Tolosa E.

Parkinsonism Relat Disord · 2015-08-12

DOI: 10.1016/j.parkreldis.2015.08.007PMID: 26306001

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

785 makale bulundu

CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations.

Phenotypical Differences in Neuronal Cultures Derived via Reprogramming the Fibroblasts from Patients Carrying Mutations in Parkinsonian Genes LRRK2 and PARK2.

Comparative blood transcriptome analysis in idiopathic and LRRK2 G2019S-associated Parkinson's disease.

Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.

A High-Throughput Screen to Identify LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease Using RapidFire Mass Spectrometry.

Fibroblast Biomarkers of Sporadic Parkinson's Disease and LRRK2 Kinase Inhibition.

Alternative to LRRK2-IN-1 for Pharmacological Studies of Parkinson's Disease.

The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway.

Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations.

Greater motor progression in patients with Parkinson disease who carry LRRK2 risk variants.

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy.

Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers.

Filtreler